Ingevity Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.2B | $1.2B | $1.2B | $1.7B | $1.4B |
| Cost of revenue | $706.1M | $735.3M | $770.5M | $1.1B | $878.7M |
| Gross profit | $461.5M | $464.8M | $445.0M | $570.1M | $512.8M |
| Selling, general & administrative | $171.2M | $157.8M | $161.8M | $198.8M | $179.3M |
| Research and development | $28.4M | $24.5M | $25.4M | $30.3M | $26.3M |
| Operating income | $418.7M | $425.9M | $423.2M | $452.6M | $422.2M |
| Interest expense | $78.3M | $97.8M | $93.3M | $61.8M | $51.7M |
| Pretax income | -$142.1M | -$140.5M | $130.0M | $269.6M | $162.8M |
| Income tax expense | $8.2M | -$19.1M | $24.2M | $58.0M | $44.7M |
| Net income | -$167.1M | -$430.3M | -$5.4M | $211.6M | $118.1M |
| Balance Sheet | |||||
| Cash and equivalents | $78.1M | $68.0M | $95.9M | $76.7M | $275.4M |
| Current assets | $454.2M | $493.2M | $658.6M | $683.3M | $724.9M |
| Total assets | $1.7B | $2.0B | $2.6B | $2.7B | $2.5B |
| Current liabilities | $341.3M | $264.1M | $362.9M | $303.5M | $268.9M |
| Total liabilities | $1.6B | $1.8B | $2.0B | $2.0B | $1.8B |
| Total debt | $1.2B | $1.4B | $1.5B | $1.5B | $1.3B |
| Stockholders' equity | $29.7M | $195.2M | $631.4M | $698.3M | $673.8M |
| Cash Flow Statement | |||||
| Cash from operations | $331.2M | $128.6M | $205.1M | $313.4M | $293.3M |
| Depreciation and amortization | $106.4M | $108.3M | $122.8M | $108.8M | $109.9M |
| Stock-based compensation | $18.3M | $11.9M | $10.6M | $16.1M | $12.3M |
| Capital expenditure | $57.7M | $77.6M | $109.8M | $142.5M | $103.8M |
| Free cash flow | $273.5M | $51.0M | $95.3M | $170.9M | $189.5M |
| Share repurchases | $56.3M | $0 | $92.1M | $145.2M | $109.4M |
| Impairments | $109.3M | $0 | $0 | $0 | $0 |
Shares outstanding 34.8M · Free float 95.6%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.